The potential neuroprotective effects of weekly treatment with glatiramer acetate in diabetic patients after panretinal photocoagulation
Somaia Mitne1,2, Sergio Henrique Teixeira1, Michal Schwartz3, Michael Belkin4, Michel Eid Farah1, Nilva S Bueno de Moraes1, Luciana da Cruz Nóia1, Ângela Tavares Paes2, Cláudio Luiz Lottenberg2, Augusto Paranhos Júnior1,21Department of Ophth...
Guardado en:
Autores principales: | Mitne S, Teixeira SH, Schwartz M, Belkin M, Farah ME, Moraes N, Nóia LC, Paes AT, Lottenberg CL, Paranhos Jr A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9d2a659c739f48d3aaf7d903c49ad408 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The role of glatiramer acetate in the early treatment of multiple sclerosis
por: David W Brandes
Publicado: (2010) -
Electroretinogram Changes Following Sequential Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
por: Khojasteh H, et al.
Publicado: (2020) -
Miniaturized high-resolution wide-field contact lens for panretinal photocoagulation
por: Koushan K, et al.
Publicado: (2014) -
Visual evoked potentials after panretinal photocoagulation in patients with proliferative diabetic retinopathy
por: Amini Vishte R, et al.
Publicado: (2019) -
Risk factors associated with progression of diabetic retinopathy in eyes treated with panretinal photocoagulation
por: Sung Uk Baek, et al.
Publicado: (2021)